DowJones News
15 Sep, 2021 12:35

DJ BSE: Medicamen Biotech Ltd. - Compliances-Reg. 39 (3) - Details Of Loss Of Certificate / Duplicate Certificate

 The following is a press release from The Stock Exchange, Mumbai: 
 Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the information regarding loss of share certificates received from the shareholders of the Company . We are in the process of issuing duplicate share certificates to them after compliance of required formalities. 
 
https://www.bseindia.com/xml-data/corpfiling/AttachLive/4d6c29f4-de97-4a8b-a259-6026ddb3937e.pdf 
 This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. 
 

(END) Dow Jones Newswires

September 15, 2021 08:35 ET (12:35 GMT)


News Source: © 2021 Web Financial Group (UK) Limited. All rights reserved and terms of use apply.

Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.

 

Important Legal Notice about News Sources

Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news articles and we may not share the views of the author or publisher.

We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.